FindTrial
Sign In

Efficacy of Diaphragmatic Release on airflow in individuals with Parkinson's Disease: randomized controlled clinical trial

Study of the effect of the Myofascial Release Technique of the diaphragm on the airflow of individuals with Parkinson's Disease: randomized controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-656kdr2
Enrollment
Unknown
Registered
2024-08-27
Start date
2024-10-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

This will be a two-arm randomized controlled clinical trial. An intervention arm and a control arm (Sham). Once included in the study, participants will draw a number to find out which group they will
E01.370.386.700.660.225.600

Sponsors

Universidade Federal do Amazonas
Lead Sponsor
Universidade Federal do Amazonas
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adult men and women (over 18 years old); with early-stage Parkinson's Disease (PD) (modified Hoen & Yahr scale 0-2.5); undergoing regular pharmacological medical treatment for PD with the use of Levodopa; physical and understanding conditions for carrying out the research; no smoking; absence of respiratory diseases or other diagnosed neurological diseases

Exclusion criteria

Exclusion criteria: Participants who miss 3 continuous sessions and those who are unable to perform the tests properly

Design outcomes

Primary

MeasureTime frame
10% improvement in peak expiratory airflow—

Secondary

MeasureTime frame
Improve chest expansion; Improve dyspnea level—

Countries

Brazil

Contacts

Public ContactEllen Souza

Universidade Federal do Amazonas

ellen.kathellen@hotmail.com+55-92-992360019

Outcome results

None listed

Source: REBEC (via WHO ICTRP)